Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Pierre-Olivier Kotzki"'
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1051 (2023)
The widespread use of peptide receptor radionuclide therapy (PRRT) represents a major therapeutic breakthrough in nuclear medicine, particularly since the introduction of 177Lu-radiolabeled somatostatin analogs. These radiopharmaceuticals have especi
Externí odkaz:
https://doaj.org/article/35384b5d6d394af0aad607e3fe005dcc
Autor:
Cyril Fersing, Emmanuel Deshayes, Sarah Langlet, Laurence Calas, Vincent Lisowski, Pierre Olivier Kotzki
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-12 (2021)
Abstract Background The purpose of this work was to design, validate and implement a media-fill test combined with fluorescein (MFT-F) for the specific qualification and training of radiopharmacy operators, in accordance with United States Pharmacope
Externí odkaz:
https://doaj.org/article/6ee7274c664d4375990780d1dd5d98a8
Autor:
Lore Santoro, Erick Mora-Ramirez, Dorian Trauchessec, Soufiane Chouaf, Pierre Eustache, Jean-Pierre Pouget, Pierre-Olivier Kotzki, Manuel Bardiès, Emmanuel Deshayes
Publikováno v:
EJNMMI Research, Vol 8, Iss 1, Pp 1-13 (2018)
Abstract Background This study’s aim was to develop our dosimetric methodology using a commercial workstation for the routine evaluation of the organs at risk during peptide receptor radionuclide therapy (PRRT) with 177Lu. Methods First, planar and
Externí odkaz:
https://doaj.org/article/875fb949447f4f1884d589e64bd0029a
Autor:
Deshayes, Thierry Galvez, Ikrame Berkane, Simon Thézenas, Marie-Claude Eberlé, Nicolas Flori, Sophie Guillemard, Alina Diana Ilonca, Lore Santoro, Pierre-Olivier Kotzki, Pierre Senesse, Emmanuel
Publikováno v:
Nutrients; Volume 15; Issue 13; Pages: 3042
18F-FDG PET-CT is routinely performed as part of the initial staging of numerous cancers. Other than having descriptive, predictive and prognostic values for tumors, 18F-FDG PET-CT provides full-body data, which could inform on concurrent pathophysio
Autor:
Laurent Maïmoun, Krishna Kunal Mahadea, Sandrine Alonso, Thierry Chevallier, Pierre‐Olivier Kotzki, Thibault Mura, Vincent Boudousq
Publikováno v:
Clinical Physiology and Functional Imaging.
Autor:
Anissa Barakat, Lore Santoro, Myrtille Vivien, Pierre-Olivier Kotzki, Emmanuel Deshayes, Sonia Khier
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics.
Publikováno v:
Pda Journal of Pharmaceutical Science and Technology
Pda Journal of Pharmaceutical Science and Technology, 2022, 76 (5), pp.416-433. ⟨10.5731/pdajpst.2021.012657⟩
Pda Journal of Pharmaceutical Science and Technology, 2022, 76 (5), pp.416-433. ⟨10.5731/pdajpst.2021.012657⟩
Gallium-68 radiolabeling is an increasingly common activity in radiopharmacy. Single vial cold kits to radiolabel DOTATOC and PSMA-11 with 68Ga were developed, either for manual or automated preparation. Both approaches are very specific and require
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a41b84943a35482afe9ec93a9cbfc1b
https://hal.science/hal-04074694
https://hal.science/hal-04074694
Autor:
Charlotte Donzé, Léa Rubira, Lore Santoro, Pierre Olivier Kotzki, Emmanuel Deshayes, Cyril Fersing
Publikováno v:
Healthcare; Volume 10; Issue 11; Pages: 2247
Securing both the patient and radiopharmaceuticals (RPs) circuit is an essential concern in nuclear medicine (NM). These circuits converge at the RP administration phase, a key step in patient management in NM. In a continuous quality improvement app
Publikováno v:
Médecine Nucléaire-Imagerie Fonctionnelle et Métabolique
Médecine Nucléaire-Imagerie Fonctionnelle et Métabolique, 2020, 44 (4), pp.261-266. ⟨10.1016/j.mednuc.2020.06.004⟩
Médecine Nucléaire
Médecine Nucléaire, Elsevier/Masson, 2020, 44 (4), pp.261-266. ⟨10.1016/j.mednuc.2020.06.004⟩
Médecine Nucléaire-Imagerie Fonctionnelle et Métabolique, 2020, 44 (4), pp.261-266. ⟨10.1016/j.mednuc.2020.06.004⟩
Médecine Nucléaire
Médecine Nucléaire, Elsevier/Masson, 2020, 44 (4), pp.261-266. ⟨10.1016/j.mednuc.2020.06.004⟩
Treatment with 131I is one of the standard treatments for benign thyroid disease. In most cases, the prescribed dose is specific for the same disease. Inspired by external radiotherapy, the emergence of personalized pre-therapeutic dosimetry in nucle
Publikováno v:
PDA journal of pharmaceutical science and technology. 76(5)
Gallium-68 radiolabeling is an increasingly common activity in radiopharmacy. Single vial cold kits to radiolabel DOTATOC and PSMA-11 with